BSA-Based Nanoparticles for Dual Loading of Pazopanib and Enzalutamide: Formulation Optimization and In Vitro Evaluation in Breast Cancer Cells
PE-BSA produced BSA particles with diffusion-governed release and enhanced 4T1 internalization, supporting albumin particles as a delivery platform to increase intracellular exposure of PAZ/ENZ in vitro.
Authors
- Özgür Eşi̇m (ORCID: https://orcid.org/0000-0002-6402-156X)
- Ayhan Savaşer (ORCID: https://orcid.org/0000-0001-8342-2919)
- Yalçın Özkan (ORCID: https://orcid.org/0000-0001-5163-6867)
- Meral Sarper (ORCID: https://orcid.org/0000-0002-9741-0641)
- Gizem Rüya Topal (ORCID: https://orcid.org/0000-0002-7715-6383)
- Kubra Kilic (ORCID: https://orcid.org/0009-0007-0699-5976)
Institutions
- University of Health Science (KH)
- Gülhane Askerî Tıp Akademisi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2026-04-13
- DOI
- https://doi.org/10.3390/pharmaceutics18040475
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00